原文 | 美式英語 |
---|---|
頁(從 - 到) | 376-376 |
期刊 | Journal of Gastroenterology and Hepatology |
卷 | 31 |
出版狀態 | 已出版 - 2016 |
Asian patients with hepatitis C (HCV) genotype 1 treated with ledipasvir and sofosbuvir (LDV/SOF) experience very high efficacy and improvement of health-related quality of life (HRQL)
Zobair Younossi, Maria Stepanova, Kwang-Hyub Han, Young-Suk Lim, Youn-Jae Lee, Wan-Long Chuang, Jia-Horng Kao, Rong-Nan Chien, Ting-Tsung Chang, Cheng-Yuan Peng
研究成果: 期刊稿件 › 文章 › 同行評審